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Candida albicans Quorum Sensing Molecules Stimulate Mouse
Macrophage Migration
Jessica C. Hargarten,a Tyler C. Moore,a* Thomas M. Petro,b Kenneth W. Nickerson,a Audrey L. Atkina
School of Biological Sciences, University of Nebraska, Lincoln, Nebraska, USAa; Department of Oral Biology, University of Nebraska Medical Center, Lincoln, Nebraska, USAb
The polymorphic commensal fungus Candida albicans causes life-threatening disease via bloodstream and intra-abdominal
infections in immunocompromised and transplant patients. Although host immune evasion is a common strategy used by suc-
cessful human fungal pathogens, C. albicans provokes recognition by host immune cells less capable of destroying it. To accom-
plish this, C. albicans white cells secrete a low-molecular-weight chemoattractive stimulant(s) of macrophages, a phagocyte that
they are able to survive within and eventually escape from. C. albicans opaque cells do not secrete this chemoattractive stimu-
lant(s). We report here a physiological mechanism that contributes to the differences in the interaction of C. albicans white and
opaque cells with macrophages. E,E-Farnesol, which is secreted by white cells only, is a potent stimulator of macrophage chemo-
kinesis, whose activity is enhanced by yeast cell wall components and aromatic alcohols. E,E-farnesol results in up to an 8.5-fold
increase in macrophage migration in vitro and promotes a 3-fold increase in the peritoneal infiltration of macrophages in vivo.
Therefore, modulation of farnesol secretion to stimulate host immune recognition by macrophages may help explain why this
commensal is such a successful pathogen.
Candida albicans is a serious fungal pathogen for humans (1). C.albicans is a dimorphic fungus and it has long been recognized
that the ability to interconvert between the yeast and filamentous
forms is essential for its pathogenicity. Thus, when we discovered
that E,E-farnesol (referred to here as farnesol) is a quorum sensing
molecule (QSM) for C. albicans which acts by blocking the con-
version of yeasts to mycelia (2), we thought that farnesol would be
an attractive lead compound in the design of novel antifungal
drugs. However, this goal was not realized when we showed that
farnesol itself acted as a virulence factor for C. albicans in a mouse
intravenous infection model (3). These observations presented a
dilemma: how can farnesol act as a virulence factor when part of its
mode of action is to block the yeast-mycelium morphogenesis,
which is necessary for its pathogenicity? We resolve this conun-
drum here by showing that farnesol is also a potent stimulator of
macrophage migration both in vitro and in vivo.
C. albicans is one of the best studied examples of an opportu-
nistic fungal pathogen. It is a normal member of the human mi-
crobiota where it is found as a commensal primarily in the gastro-
intestinal and genitourinary tracts and on the skin of healthy
individuals without causing significant disease. In healthy individ-
uals, C. albicans commensals are controlled but tolerated while C.
albicans pathogens are eliminated (reviewed in reference 4). The
presence of innate immune phagocytes, which include both mac-
rophages and neutrophils, is critical for early detection and elim-
ination of C. albicans that have made the transition from com-
mensal to an opportunistic pathogen (5–9; reviewed in reference
10). Thus, when normal immune responses are compromised, C.
albicans can transition easily from a commensal to an opportunis-
tic pathogen.
Another part of the transition from commensalism to patho-
genicity is the ability of C. albicans strains that are homozygous at
the mating type locus to reversibly convert between two distinct
yeast phenotypes, the normal yeast morphology (white) and the
mating competent elongated cell type (opaque [11–13]). Approx-
imately 3% of natural isolates are homozygous at the mating type
locus (11). The white and opaque morphologies of C. albicans are
also specifically adapted to colonize distinct host niches; the
opaque morphology is best adapted to colonize the skin commen-
sally, whereas the white morphology is commonly associated with
systemic infections. Critically, these two yeast morphologies also
elicit different responses from host phagocytes, which may ac-
count for the partitioning of these morphologies during patho-
genesis. First, opaque C. albicans only stimulates the random
movement of polymorphonuclear leukocytes, including neutro-
phils, whereas the white phase secretes an unknown chemoattrac-
tant(s) that stimulates chemotactic migration directly toward the
yeast cells (14). Second, in a study comparing the engulfment of
white and opaque cells by macrophages, it was found that a mouse
macrophage cell line (RAW264.7 cells) and a Drosophila melano-
gaster hemocyte-derived cell line (S2) both engulfed white C. al-
bicans much more effectively than they did opaque cells (15). This
difference is intriguing because engulfed white cells are able to
survive within and then escape from macrophages in vitro (16–
18). This in vitro result is compatible with the importance of mac-
rophages in vivo for the early elimination of C. albicans (19, 20)
because macrophages which have engulfed C. albicans secrete im-
munoregulatory cytokines including interleukin-6 (IL-6), IL-1,
IL-10, and tumor necrosis factor alpha (TNF-) (21) prior to the
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escape of C. albicans. These cytokines presumably promote the
development and chemotactic migration of other innate immune
cells, including neutrophils, which are more capable of killing C.
albicans (22). Even though evading host immunity is a common
strategy used by pathogenic fungi (23–25), we hypothesize C. al-
bicans white cells produce a chemoattractive stimulant(s) that
promotes their engulfment by macrophages. This may explain
why C. albicans is so virulent in immunocompromised individu-
als, particularly those with neutropenia (1). One likely candidate
for a phagocyte chemoattractive stimulant is the QSM farnesol.
Farnesol is an appealing candidate because it is produced by white
cells but not by opaque cells (26), and it is already a known viru-
lence factor for C. albicans (3). Moreover, farnesol was previously
found to activate neutrophils and stimulate proinflammatory cy-
tokine production by monocytes, while dampening dendritic cell
activity as antigen-presenting cells (21, 22). We show here that the
farnesol excreted by C. albicans stimulates macrophage migration
by promoting chemokinesis rather than chemotaxis.
MATERIALS AND METHODS
C. albicans strains, media, and growth conditions. The C. albicans wild-
type clinical isolates SC5314 (MTLa/MTL) and WO-1 (MTL/MTL)
were obtained from Alexander Johnson, University of California at San
Francisco, and David Soll, University of Iowa, respectively.
Synthetic complete (SC) medium with uridine at 100 g/ml in place of
uracil (27) was used for routine growth and maintenance of the C. albicans
strains. Resting cells were prepared as described by Kebaara et al. (28),
with the following modifications: single colonies were grown in 25 ml of
SC broth at 30°C for 24 h to reach stationary phase, washed three times
with 1 phosphate-buffered saline (PBS), resuspended in the same buf-
fer, and stored at 4°C overnight before use. Resting cells were kept no
longer than 1 week at 4°C.
For gas chromatography-mass spectrometry (GC-MS) analysis, single
colonies of C. albicans strains SC5314 and WO-1 (both the white and
opaque morphologies) were inoculated into 50 ml of GPP medium (29)
and grown at 30°C with 225 rpm aeration until early stationary phase,
when the supernatants were harvested, immediately extracted, and de-
rivatized. Microscopically, the opaque cultures appeared to have 100%
opaque cells at the times of both inoculation and harvesting.
GC-MS measurement of aromatic alcohol concentrations in C. al-
bicans cell-free supernatants. The cell-free supernatants were extracted
with ethyl acetate and derivatized prior to GC-MS analysis as described
previously (2) with the following modifications. Derivatization of the hy-
droxyl groups on the aromatic alcohols was accomplished by adding 100
l of BSTFATMCS (99:1; Sylon BFT kit; Supelco Analytical, Bellefonte,
PA) and incubating the samples for 1 h at 50°C in a water bath. After
cooling, the samples were submitted directly for GC-MS.
Cell culture and mice. RAW264.7 cells were obtained from the Amer-
ican Type Culture Collection (Rockville, MD) and maintained in culture
medium (Dulbecco modified Eagle medium [DMEM] with 10% fetal
bovine serum [FBS] and 50 g of gentamicin/ml) at 37°C in the presence
of 5% CO2. RAW 264.7 cells were passaged in fresh culture medium every
2 to 3 days and seeded into fresh serum-starved culture medium (DMEM
with 0.5% FBS and 50 g of gentamicin/ml) overnight prior to use in
chemotaxis experiments. Only cells from passages 5 through 15 were used
for chemotaxis experiments.
Female 8- to 12-week-old C57BL/6 mice were obtained from Jackson
Laboratories (Bar Harbor, ME). Female 8- to 12-week-old B10.s mice
were offspring of breeder pairs obtained from Michel Brahic (Stanford
University). All experiments involving mice were performed in accor-
dance with the recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. Our protocol was
approved by the University of Nebraska-Medical Center Institutional An-
imal Care and Use Committee. All animals were housed and used in
accordance with institutional guidelines, and all efforts were made to min-
imize suffering of animals.
Primary mouse PEC preparation. Mouse peritoneal exudate cells
(PECs) were elicited by intraperitoneal (i.p.) injection of 2 ml of thiogly-
colate broth. Four days later, the peritoneal cavities were flushed with 2 ml
of DMEM, and the cells obtained were incubated at 106 cells/2 ml of
DMEM cell culture medium (Invitrogen, Carlsbad, CA) containing 10%
FBS (Invitrogen) and 50 g of gentamicin/ml (Invitrogen). These cells
were used immediately in the mouse PEC chemotaxis assays.
Mouse macrophage chemotaxis assay. Primary C57BL/6 PECs and
RAW264.7 cells were cultured as described above. The migration of both
cell types was measured using the CytoSelect 96-well cell migration assay
kit according to product specifications (Cell Biolabs, San Diego, CA).
Briefly, aliquots of 106 cells in culture media were placed into the top
chamber of a 5-m-pore-size polycarbonate membrane transwell plate.
Chemoattractant solutions were placed in the bottom chamber. Cells
were incubated with each chemoattractant solution for 2 h, at which time
the migratory cells were harvested, lysed, and measured by the fluores-
cence of macrophage nuclei normalized to a control of culture medium
without macrophages (normalized RFU). Farnesol was added from a 100
mM stock in methanol prepared fresh each use. Stock solutions of zymo-
san A (25 mg/ml in PBS) and aromatic alcohols (100 mM in methanol)
were also diluted into DMEM, and 1% methanol in DMEM was used as a
negative control, whereas 50 ng of monocyte chemotactic protein 1
(MCP-1)/ml in DMEM was used as a positive control.
To test the migratory potential of macrophages toward C. albicans-
secreted QSMs, supernatants were harvested from early stationary-phase
C. albicans cultures grown in 25 ml of SC or GPP medium at 30°C with
225-rpm aeration. The supernatants were passed twice through a 20-m-
pore-size nitrate cellulose filter to ensure all C. albicans cells were removed
prior to the addition of 40 to 120 l of DMEM in the bottom chamber of
the transwell plate.
To test whether farnesol stimulates chemotaxis or chemokinesis, the
migration of RAW 264.7 cells was measured using the Neuro Probe
ChemoTx system according to product specifications using a checker-
board assay (Neuro Probe, Gaithersburg, MD). Briefly, the bottom wells
of the NeuroProbe ChemoTx System chamber were filled with 300 l of
medium containing or lacking farnesol. Then, 40 l of 106 RAW 264.7
cells/ml suspended in culture medium (DMEM  0.5% FBS) containing
or lacking farnesol was placed on top of a 5-m-pore-size polycarbonate
membrane filter. The ChemoTx System was incubated at 37°C and 5%
CO2 for 6 h. After incubation, nonmigratory cells were removed from the
filter surface, and adherent cells that migrated through the filter were
detached through addition of 2.5 mM EDTA-PBS to the top of the filter
and allowed to incubate for 30 min at room temperature, followed by
centrifugation of the plate at 1,400 rpm for 5 min. Migratory cells were
examined microscopically and five fields of cells (from a total well area of
25.5 mm2) were counted per well with five replicate wells per treatment.
Mice and in vivo chemotaxis assay. As described by Navarathna et al.
(3), commercial E,E-farnesol (Sigma-Aldrich, St. Louis, MO) was diluted
in 0.5% (vol/vol) Tween 80 (Sigma-Aldrich) in sterile, nonpyrogenic PBS.
Mice were injected i.p. with 1 ml of fresh 20 mM (4.4 mg) E,E-farnesol
dissolved in 0.5% Tween 80, aged thioglycolate broth, or 0.5% Tween 80.
Three days later, the peritoneal cavities were flushed with 2 ml of DMEM,
and the PECs were counted. To assay for macrophage populations within
the peritoneum, the PECs were stained with peridinin chlorophyll pro-
tein-labeled anti-CD11c and fluorescein isothiocyanate-labeled anti-CD11b
in the presence of Fc Block (2.4G2; all antibodies were purchased from eBio-
sciences, San Diego, CA). After surface staining, the cells were fixed in 1%
paraformaldehyde and analyzed using a Becton Dickinson FACSCalibur, and
the data were processed using FlowJo software (Tree Star, San Carlos, CA).
Statistical analysis. A Student two-tailed unpaired t test was used to
determine the significance of differences between means for transwell che-
motaxis experiments with relative fluorescence measurements of migration
(*, P  0.05; **, P  0.001). The GLIMMIX procedure in SAS (SAS Institute,
Hargarten et al.
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Inc., Cary, NC) was used to determine the treatment least-squares means for
transwell chemotaxis experiments with cells/field counts (*, P  0.05; **, P 
0.001). The cutoff for statistical significance was set at a P value of 0.05.
Statistical analyses were performed using GraphPad Prism 5.0 (GraphPad
Software, San Diego, CA) for transwell chemotaxis experiments with relative
fluorescence measurements of migration, and using SAS for the transwell
chemotaxis experiment with cells/field counts.
RESULTS
Macrophages preferentially migrate toward supernatants of C.
albicans white cells. White-cell supernatants of C. albicans, but
not opaque-cell supernatants, stimulate chemotaxis of neutro-
phils (14). Since macrophages interact differently with opaque
cells compared to white cells (15, 20), we hypothesized that, like
neutrophils, macrophages might display differential migration
patterns toward white and opaque C. albicans. We first sought to
determine whether C. albicans white-cell supernatants preferen-
tially stimulate macrophage migration relative to the opaque-cell
supernatants as assayed by a transwell cell migration (Fig. 1A).
Briefly, 106 serum-starved RAW 264.7 cells were incubated in cell
culture medium (i.e., DMEM), while separated from possible che-
FIG 1 Cell-free supernatants of C. albicans and biologically relevant concentrations of E,E-farnesol enhance chemokinesis of mouse phagocytes. (A and B)
Two-hour migration of mouse macrophage cells toward cell-free supernatants obtained from C. albicans growing in the white (SC5314 and WO-1) and opaque
(WO-1) morphologies, compared to the negative DMEM control and the MCP-1 positive control (MCP-1, 250 ng/ml). Migration was measured by the
fluorescence in the lower well of macrophage nuclei normalized to a DMEM control without macrophages (normalized RFU). Cell-free supernatants were
prepared from C. albicans cells grown to saturation in synthetic complete medium at 30°C, some of which were supplemented with biologically relevant
concentrations of farnesol immediately prior to the chemotaxis assay. (C and D) Biologically relevant concentrations of farnesol stimulate the migration of cells
from the mouse cell line RAW 264.7 (C) or primary C57BL/6 PECs (D). (E) Six-hour migration of RAW 264.7 cells toward 20 M farnesol (FOH) added from
a 100 mM stock in methanol prepared fresh for each use. Methanol itself does not stimulate macrophage migration (far-left bar). All graphs show the means 	
the standard errors of the mean (SEM) for at least four replicate wells (five replicate wells for panel E) and are representative of three independent experiments.
(*, P  0.05; **, P  0.001).
E,E-Farnesol Stimulates Macrophage Chemokinesis
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moattractants in the respective supernatants by a permeable
membrane with a 5-m-pore-size cutoff. Macrophages attracted
to potential chemoattractants distend their pseudopodia and mi-
grate through the membrane toward the chemoattractant. After 2
h, macrophage migration into the lower chamber was quantified
by fluorescently staining the macrophage nuclei. Separate cohorts
of RAW 264.7 cells were incubated with uninoculated macro-
phage cell culture medium or with MCP-1 (30, 31) as negative and
positive controls, respectively (Fig. 1A). Significantly, superna-
tants from two C. albicans strains, SC5314 and WO-1, stimulated
3-fold more RAW 264.7 cell migration than did 250 ng of MCP-
1/ml. In addition, the supernatants from WO-1 white cells stim-
ulated 2.3-fold-greater migration than the supernatants from
WO-1 opaque cells (Fig. 1A). WO-1 opaque-cell supernatants and
MCP-1 stimulated similar amounts of RAW 264.7 cell migration.
Thus, SC5314 and WO-1 white-cell supernatants contain secreted
molecules that stimulate significantly more macrophage migra-
tion than supernatants from opaque cells even though these
strains differ at their MTL locus because SC5314 is heterozygous
for the MTLa and MTL alleles, whereas WO-1 is homozygous for
the MTL allele (11).
The fungal quorum sensing molecule farnesol stimulates the
migration of macrophage in vitro. Farnesol is produced naturally
by both C. albicans SC5314 and WO-1 white cells at concentra-
tions of 2 to 100 M (32) but not by opaque cells (26), and thus it
is a candidate for the white-cell factor that stimulates positive
migration of macrophages. We tested the ability of farnesol to
promote migration of both RAW 264.7 cells (Fig. 1C) and primary
peritoneal exudate cells (PECs) containing 90% inflammatory
macrophages (Fig. 1D). Biologically relevant concentrations of
farnesol (2 to 60 M) were sufficient to promote increases in the
migration of RAW 264.7 cells and PECs in a dose-dependent man-
ner up to concentrations of farnesol that are toxic for macro-
phages in cell culture (80 to 100 M) (Fig. 1C and D and data not
shown). Farnesol stimulated up to 8.5- and 5-fold more RAW
264.7 and PEC migration, respectively. Methanol at 0.1%, a vehi-
cle control, did not promote migration of either RAW 264.7 cells
or PECs (data not shown). Moreover, the addition of biologically
relevant concentrations of farnesol (20 M) added to opaque
supernatants was sufficient to stimulate an increase in the migra-
tion of RAW 264.7 cells to the same level, as was seen with white-
cell supernatants (Fig. 1B), whereas 20 M farnesol did not.
Together, these data suggest that farnesol secreted by C. albicans
white cells promotes the migration of macrophages.
Farnesol stimulates chemokinesis of macrophages in vitro.
Neutrophils respond to C. albicans white-cell supernatants by
positive chemotaxis and opaque-cell supernatants by chemokine-
sis (14). Chemotaxis is directed movement up a chemical concen-
tration gradient, whereas chemokinesis is gradient-independent
activation of movement in response to a chemical stimulus. To
determine whether the observed induction of migration of RAW
264.7 cells in response to farnesol was due to chemotaxis or
chemokinesis, RAW 264.7 cell migration was evaluated in a trans-
well checkerboard migration assay with 20 M farnesol in the
lower well (
/FOH), the upper well (FOH/
), or both wells
(FOH/FOH; Fig. 1E). As before, the RAW 264.7 cells were added
to the top well and detected in the bottom well. Consistently,
farnesol in the lower well led to macrophage migration from the
upper to the lower transwell. Significantly, farnesol added to the
upper well also enhanced the migration of macrophages regard-
less of whether farnesol was present in the lower well (Fig. 1E); a
chemical gradient of farnesol was not necessary. These data sug-
gest that farnesol acts as a stimulant for chemokinesis, not che-
motaxis.
For neutrophils, Geiger et al. (14) showed that the chemoat-
tractants released by C. albicans included at least two components
responsible for chemokinesis and chemotaxis. These authors fur-
ther showed that chemokinesis and chemotaxis were separable
and that one of the components necessary for chemotaxis was a
peptide of 1,000 Da because boiling and treatment with protei-
nase K removed the chemotactic but not the chemokinetic activ-
ity. We have now demonstrated, at least for macrophages, that the
component responsible for chemokinesis is likely farnesol. Thus,
the two activities can be readily distinguished on the basis of the
chemical and physical properties of their active components. As
we showed when we first identified farnesol as a quorum sensing
molecule (2), farnesol (222 Da) is lipid soluble, extractable into
ethyl acetate or hexane, stable at 100°C for 30 min, and insensitive
to trypsin, pronase, thermolysin, and proteinase K. However, it is
still unclear whether cell chemotaxis requires a combination of
farnesol and the 1-kDa peptide or whether the peptide by itself is
sufficient.
Aromatic alcohols and cell wall components enhance macro-
phage migration in response to farnesol. In the context of C.
albicans interactions with the human host, the innate immune
system encounters farnesol as part of a complex mixture of immu-
nostimulatory and immunosuppressive signals. C. albicans im-
munomodulatory signals come in the form of cellular debris from
dead and dying cells, as well as from excreted metabolic products.
Two possible immunomodulatory signals common to both the
white and opaque morphologies of C. albicans are fungal cell wall
carbohydrates and the aromatic alcohols tyrosol, tryptophol, and
phenethyl alcohol (21, 33–35). Thus, these immunomodulatory
signals were tested for their chemotactic potential both on their
own and in combination with farnesol. Zymosan A, a protein-
carbohydrate complex prepared from yeast cell walls, stimulates
macrophage to express both inflammatory and regulatory cyto-
kines as mediated through a Toll-like receptor 2 (TLR2) and Dec-
tin-1 response (21, 36, 37). We therefore sought to determine
whether zymosan A could stimulate mouse macrophage migra-
tion on its own or enhance the migration-stimulating activity of
farnesol. Zymosan A (25 g/ml) alone does not stimulate move-
ment of RAW 264.7 cells (Fig. 2A) or primary PECs (Fig. 2B), and
it did not enhance macrophage movement due to farnesol (Fig.
2A). These data suggest that even though zymosan A stimulates
the expression of both inflammatory and regulatory cytokines, it
does not stimulate macrophage chemotaxis or chemokinesis due
to farnesol.
Secretion of the aromatic alcohols (tyrosol, phenethyl alcohol,
and tryptophol) influences growth, morphogenesis, and biofilm
formation by C. albicans (reviewed in reference 38), but their role
in the innate immune response to C. albicans is currently un-
known. Biologically relevant concentrations of aromatic alcohols
did not stimulate the migration of mouse macrophages (Fig. 2A)
or primary PECs (Fig. 2B), a finding that is consistent with the
observation that white and opaque cells both secrete significant
levels of these aromatic alcohols (Table 1). However, their combi-
natorial chemotactic potential was evident in that the combina-
tion of aromatic alcohols and farnesol stimulated RAW 264.7 cell
migration 1.6-fold better than did farnesol alone (Fig. 2A), and the
Hargarten et al.
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combinations of all three signals (zymosan A, aromatic alcohols,
and farnesol) were 2.0- and 1.3-fold better than farnesol alone or
in combination with the aromatic alcohols, respectively (Fig. 2A).
In summary, our results show that zymosan A and the aromatic
alcohols do not stimulate the migration of phagocytes on their
own, but they do enhance the migration stimulated by farnesol.
Farnesol stimulates the migration of macrophages into the
peritoneum in vivo. The results thus far demonstrate that farne-
sol has chemokinetic activity toward macrophages in vitro. There-
fore, we wondered whether farnesol also elicits macrophage mi-
gration in vivo. Accordingly, B10.s mice were injected i.p. with 1
ml of 20 mM farnesol in 0.5% Tween 80-PBS and 3 days later PECs
were collected and analyzed by flow cytometry (Fig. 3A, middle).
This farnesol concentration and delivery vehicle were chosen to
replicate our previous work in a mouse model of systemic candi-
diasis, which showed that farnesol is a virulence factor (3). Sepa-
rate cohorts of mice were injected with either 1 ml of 0.5% Tween
80-PBS or 2 ml of sterile thioglycolate broth to serve as negative
and positive controls, respectively (Fig. 3A, left and right). Mac-
rophages and dendritic cells in the PEC populations were quanti-
fied by staining with fluorescent antibodies to CD11b and CD11c
(Fig. 3). Mice injected with farnesol had a nearly 3-fold increase in
the percentage of PECs that were CD11bhi cells (indicative of mac-
rophages) compared to Tween 80-PBS alone (Fig. 3B). This in-
crease with farnesol was 1.6-fold greater than that which oc-
curred with the thioglycolate positive control (Fig. 3B). In
addition, the absolute number of CD11bhi cells recovered from
the PECs of farnesol-treated mice was 60-fold greater than that
with Tween 80-PBS alone (Fig. 3C).
In contrast to farnesol stimulating macrophage influx into the
peritonea of mice, mice injected with the vehicle control had a
1.5-fold increase in the percentage of CD11chi/CD11blo PECs (in-
dicative of dendritic cells) compared to farnesol (Fig. 3D). This
decrease in farnesol recruitment of dendritic cells was also seen
relative to thioglycolate-injected mice. Thioglycolate-treated mice
showed an 4.5-fold greater percentage of CD11chi/CD11blo
PECs than the farnesol-treated mice (Fig. 3D) and a nearly 6-fold
increase in the absolute number of CD11chi/CD11blo cells in the
peritoneum compared to farnesol-treated mice (Fig. 3E). There-
fore, farnesol is a significant stimulator of macrophage migration,
but not dendritic cell migration in vivo.
DISCUSSION
In this study, we show that farnesol, which is secreted by C. albi-
cans white cells, but not by opaque cells (26), modulates innate
immune responses by directly stimulating movement of macro-
phages thus explaining the greater engulfment of white cells as
observed by Lohse and Johnson (15). These results suggest that
production of farnesol by C. albicans white cells contributes to
virulence by stimulating macrophages. In contrast, the lack of
farnesol production by opaque-phase cells leads to less macro-
phage stimulation and attenuated virulence. These results are also
consistent with the differences in virulence seen for C. albicans
cells that produce different levels of farnesol. For example, C. al-
bicans pretreated with subinhibitory levels of fluconazole pro-
duced up to 12-fold more farnesol and were up to 8.5-fold more
lethal (39), while C. albicans cells lacking DPP3 produced 6-fold
TABLE 1 C. albicans white- and opaque-phase cells secrete significant
concentrations of the aromatic alcohols phenethyl alcohol, tyrosol, and
tryptophol
C. albicans WO-1
cell phase
Mean g aromatic alcohol/g (dry wt) 	 SEMa
Phenethyl
alcohol Tryptophol Tyrosol
White 2,990 	 803 439 	 360 31.5 	 16.7
Opaque 732 	 543 198 	 12.6 2.72 	 2.14
a GC-MS analysis was performed on cell-free supernatants of C. albicans WO-1 white-
and opaque-phase cells grown at 30°C aerobically in defined GPP medium until early
stationary phase. Throughout, phenethyl alcohol, tyrosol, and tryptophol are expressed
as micrograms per gram (dry weight) of fungal cells. Data are the averages from
triplicate experiments.
FIG 2 Zymosan A and aromatic alcohols do not stimulate macrophage mi-
gration individually, but aromatic alcohols with or without zymosan A en-
hance farnesol-mediated migration of mouse phagocytes. The results from a
1-h migration of cells from the mouse macrophage cell line, RAW 264.7 (A), or
primary C57BL/6 mouse PECs (B) toward 20 M farnesol, yeast cell wall
components (25 g of zymosan A/ml), and the aromatic alcohols tyrosol,
tryptophol, and phenethyl alcohol (1 M each) as measured by normalized
relative fluorescent units (RFU), are shown. Zymosan A (25 mg/ml) in PBS
and 100 mM aromatic alcohols in methanol (prepared fresh for each use) were
diluted into DMEM. Then, 1% methanol in DMEM was used as a negative
control. Although methanol is toxic to macrophages, the macrophages and
C57BL/6 PECs remained viable in up to 1% methanol during the time frame of
this experiment. Graphs show the means 	 the SEM for at least four replicate
wells and are representative of three independent experiments (*, P  0.05; **,
P  0.001).
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less farnesol and were 4.2-fold less pathogenic (3). Further, C.
albicans ATCC 10231, a natural strain that produces farnesoic
acid, but not farnesol is 10-fold less pathogenic (3). These results
are significant because the ineffectiveness of macrophages in kill-
ing phagocytosed C. albicans helps to explain why farnesol is a
virulence factor even though in vitro it also prevents yeast-fila-
ment morphogenesis, an important virulence trait.
Our observation that farnesol stimulates macrophages to mi-
grate is consistent with work showing that farnesol affects aspects
of host immune responses differently (21, 22). Recently, Leon-
hardt et al. (22) showed that neutrophils, which are more capable
of killing C. albicans (19, 20), are only weakly stimulated by farne-
sol at physiologically relevant concentrations (50 to 100 M).
Similarly, monocytes are stimulated by farnesol to produce pro-
inflammatory cytokines (21, 22). In contrast, the differentiation of
monocytes into dendritic cells and their subsequent migrational
behavior are impaired by farnesol (22). Taken together, these ob-
servations suggest in part that farnesol acts as a virulence factor by
dampening the adaptive immune response while stimulating the
innate immune response. This distinction is important for two
reasons. First, we and others have shown that C. albicans cells that
are phagocytosed by macrophages respond by forming hyphae
FIG 3 Farnesol promotes the peritoneal infiltration of macrophages in vivo. B10.s mice were injected i.p. with 1 ml of 0.5% Tween 80-PBS alone (TWEEN-80)
or 1 ml of 20 mM farnesol in 0.5% Tween 80-PBS. Three days later, the PECs were harvested, and the presence of CD11b and CD11c, cell surface markers for
macrophages, was quantified by fluorescent antibody staining and flow cytometry. As a positive control, mice were injected i.p. with 2 ml of thioglycolate broth,
and the PECs were harvested 4 days later. Representative flow cytometric plots (A), quantification of percent CD11bhi cells in PECs per mouse (B), and
quantification of the absolute number of CD11bhi cells per mouse (C) are shown. Similarly, quantification of the percent CD11chi/CD11blo cells in PECs per
mouse (D) and quantification of the absolute number of CD11chi/CD11blo cells per mouse (E) are shown. These results are representative of three independent
experiments.
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that penetrate the macrophage plasma membrane, thus killing the
macrophages 3 to 6 h after ingestion and thereby permitting their
escape (16–18). Significantly, this escape may occur at a location
in the host far distant from where the C. albicans was phagocyto-
sed. Second, suppression of the dendritic cell activity with regard
to antigen presentation to T cells of the adaptive arm of the im-
mune system suggests that the host can only develop an inefficient
adaptive response to Candida. Thus, farnesol can modulate the
host immune response to favor its survival and dissemination
within its host.
We speculate that C. albicans, through control of the white-
opaque switch, evolved to stimulate macrophages for dissemina-
tion through the host. This idea suggests that the first step in the
“Trojan horse strategy” for dissemination of some bacterial and
viral pathogens (40, 41) is also used by C. albicans (19, 42). In
terms of the overall balance between host and pathogen, it is
highly relevant that prior to their death, macrophages that ingest
C. albicans secrete immunoregulatory cytokines, including IL-6,
IL-1, IL-10, and TNF- (21), presumably in order to promote
the development and chemotactic migration of other, more capa-
ble members of the innate immune system, such as neutrophils
(19, 20). This idea is consistent with the importance of macro-
phages in early elimination of C. albicans (43, 44), as well as the
predisposition to invasive candidiasis of patients with neutrope-
nia (1). We have not yet determined whether farnesol is a che-
moattractive stimulant for neutrophils to the same degree as it is
for macrophages.
The roles of phagocytic cells in controlling candidiasis in
healthy and immunocompromised individuals are not well un-
derstood. However, information about small signaling molecules,
such as farnesol, possibly secreted by the gut microbiota may be
helpful to tease apart these differences. In immunocompromised
hosts secretion of farnesol may promote C. albicans dissemination
through macrophages as described above. This model could ex-
plain in part the high level (70%) of systemic candidiasis in im-
munodeficient small bowel transplant recipients (45, 46). This
scenario is potentially even more profound in patients with neu-
tropenia treated with classes of antifungal drugs that enhance the
production of farnesol by C. albicans (47–49). In contrast, in im-
munocompetent hosts, farnesol detection may serve a critical sur-
veillance function for the phagocytes in controlling fungal dissem-
ination. Thus, through the modulation of QSM expression, C.
albicans has the potential to directly control its fate within the
host.
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